Should my patient continue iron supplementation given a serum iron of 36 µg/dL, total iron‑binding capacity of 344 µg/dL, and transferrin saturation of 11%?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Yes, continue iron supplementation—your patient has clear iron deficiency

With a transferrin saturation of 11% (well below the 20% threshold) and serum iron of 36 µg/dL, your patient definitively requires continued iron supplementation. These values indicate inadequate iron availability for erythropoiesis, regardless of the clinical context.

Iron Status Interpretation

Your patient's labs demonstrate iron deficiency by multiple criteria:

  • Transferrin saturation of 11% is markedly below the diagnostic threshold of 16-20% used across guidelines 1, 2
  • The lower the TSAT and serum ferritin, the higher the likelihood of iron deficiency 1
  • A TSAT <20% has high sensitivity for diagnosing absolute or functional iron deficiency 3

The TIBC of 344 µg/dL (elevated-normal range) further supports iron deficiency, as TIBC increases when iron stores are low 2.

Critical Missing Information

You must obtain a serum ferritin level to complete the iron status assessment and guide treatment intensity 1, 3. The ferritin will distinguish between:

  • Absolute iron deficiency: Ferritin <30-45 µg/L in general population 4 or <100 ng/mL in CKD patients 1
  • Functional iron deficiency: Ferritin 100-800 ng/mL with low TSAT, indicating iron stores cannot mobilize fast enough for erythropoiesis 1

Treatment Recommendations

Oral Iron Supplementation

For most patients without CKD or malabsorption:

  • Continue oral iron at 200 mg elemental iron daily 1
  • Take with meals if GI side effects occur 5
  • Separate from antibiotics by 2 hours 5

When to Consider IV Iron

Switch to intravenous iron if your patient has 1, 3:

  • Chronic kidney disease (especially hemodialysis)
  • Inflammatory bowel disease
  • Intolerance to oral iron
  • Ongoing blood losses exceeding oral absorption capacity
  • Need for erythropoiesis-stimulating agents

Treatment Targets

Aim for 1, 3:

  • TSAT ≥20% (your patient is at 11%, needs significant repletion)
  • Ferritin ≥50 ng/mL in general population without inflammation 3
  • Ferritin ≥100 ng/mL if on dialysis or receiving EPO 1

Monitoring Plan

Recheck labs 4-8 weeks after initiating/continuing therapy 3:

  • Complete blood count (hemoglobin should increase 1-2 g/dL)
  • Iron panel (serum iron, TIBC, TSAT)
  • Serum ferritin (essential for ongoing management)

Common Pitfalls to Avoid

  1. Don't stop iron based on TSAT alone—ferritin is needed to assess total body iron stores 1
  2. Don't check iron parameters within 4 weeks of IV iron—circulating iron interferes with assays 3
  3. Ferritin is an acute phase reactant—inflammation can falsely elevate it, masking true iron deficiency. If ferritin is 45-150 µg/L with low TSAT, consider iron deficiency even with "normal" ferritin 1, 4
  4. Oral iron absorption is limited—even 200 mg daily may be insufficient if there are ongoing losses or increased erythropoietic demand 1

Your patient's TSAT of 11% leaves no ambiguity: iron supplementation must continue and likely needs intensification once ferritin results guide the specific approach.

References

Related Questions

What does an iron panel showing total iron‑binding capacity 368 µg/dL, ferritin 15 µg/L, serum iron 128 µg/dL, and transferrin saturation 35% indicate, and how should it be managed?
What is the interpretation of an iron panel showing low serum iron, low transferrin saturation, normal ferritin, and normal‑high total iron‑binding capacity, and what management steps are recommended?
What does a total iron‑binding capacity of 204 µg/dL, serum iron of 69 µg/dL, and transferrin saturation of 34% indicate about the patient's iron status and need for supplementation?
In an adult with normal hemoglobin, serum ferritin, and serum iron but elevated total iron‑binding capacity (TIBC), should iron supplementation be started?
My iron studies show total iron 70 mcg/dL (reference 40‑190), total iron‑binding capacity 364 mcg/dL (reference 250‑450), transferrin saturation 19 % (reference 16‑45), and ferritin 15 ng/mL (reference 16‑154). What does this indicate and what should I do?
What is the recommended management for a child with idiopathic generalized epilepsy, including first-line drug selection based on seizure type, dosing, monitoring, and follow-up?
What is the recommended treatment for a 25-year-old female with severe bone pain, underweight status, and presumed osteoporosis?
Should cardiac magnetic resonance imaging (CMR) be used to evaluate for intracardiac thrombus in this patient?
How should I manage an adult with a TSH of 34.5 mIU/L and a free T4 of 0.79 ng/dL?
What ICD‑10 code should be used to prescribe Blisovi 24 Fe (norethindrone acetate + ethinyl estradiol) for a reproductive‑age woman without contraindications?
A 16-year-old adolescent with medial elbow pain for more than two weeks, a positive ulnar collateral ligament (UCL) stress test, and a normal plain radiograph—what is the appropriate management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.